Does pandemic A/H1N1 virus have the potential to become more pathogenic?

mBio

Volumn 1, Issue 5, 2010, Pages

  Ilyushina, Natalia A ^a,b,d   Ducatez, Mariette F ^a   Rehg, Jerold E ^a   Marathe, Bindumadhav M ^a   Marjuki, Henju ^a   Bovin, Nicolai V ^c   Webster, Robert G ^a   Webby, Richard J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^c SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2,6 SIALYL RECEPTOR; OSELTAMIVIR; POLYMERASE ACIDIC PROTEIN; RECEPTOR; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME ACTIVITY; FERRET; GENETIC REASSORTMENT; GENOTYPE; HUMAN; HUMAN CELL; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; KIDNEY CELL; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RECEPTOR BINDING; STRAIN DIFFERENCE; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS MUTATION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; CELL LINE; COCULTURE TECHNIQUES; DNA-DIRECTED RNA POLYMERASES; FERRETS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MUTATION, MISSENSE; ORTHOMYXOVIRIDAE INFECTIONS; REASSORTANT VIRUSES; VIRULENCE;

MUSTELA; ORTHOMYXOVIRIDAE;

EID: 79952174174     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00249-10     Document Type: Article

References (20)

1. Kilbourne, E. D. 2006. Influenza pandemics of the 20th century. Emerg. Infect. Dis. 12:9-14.
2. World Health Organization. 2009. Global alert and response: pandemic (H1N1)-update 58. http://www.who.int/csr/don/2009_07_06/en/index.html. Accessed 6 July 2010.
3. Hurt, A. C., J. K. Holien, M. W. Parker, and I. G. Barr. 2009. Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses. Drugs 69:2523-2531.
4. Janies, D. A., I. O. Voronkin, J. Studer, J. Hardman, B. B. Alexandrov, T. W. Treseder, and C. Valson. 2010. Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread cocirculation of the lineages. Int. J. Health Geogr. 9:13.
5. Peacey, M., R. J. Hall, S. Sonnberg, M. Ducatez, S. Paine, M. Nicol, J. C. Ralston, D. Bandaranayake, V. Hope, R. J. Webby, and Q. S. Huang. 2010. Pandemic (H1N1) 2009 and seasonal influenza A (H1N1) coinfection, New Zealand, 2009. Emerg. Infect. Dis. 16(10):1618-1620.
6. Perez, D. R., E. Sorrell, M. Angel, J. Ye, D. Hickman, L. Pena, G. Ramirez-Nieto, B. Kimble, and Y. Araya. 2010. Fitness of pandemic H1N1 and seasonal influenza A viruses during co-infection: evidence of competitive advantage of pandemic H1N1 influenza versus seasonal influenza. PLoS Curr. 1:RRN1101.
7. World Health Organization. 2009. Global alert and response: pandemic (H1N1)-update 103. http://www.who.int/csr/don/2010_06_04/en/index.html. Accessed 6 July 2010.
8. Ducatez, M. F., S. Sonnberg, R. J. Hall, M. Peacey, J. Ralston, R. J. Webby, and Q. S. Huang. 2010. Genotyping assay for the identification of 2009-2010 pandemic and seasonal H1N1 influenza virus reassortants. J. Virol. Methods 168:78-81.
9. Matrosovich, M. N., A. S. Gambaryan, A. B. Tuzikov, N. E. Byramova, L. V. Mochalova, A. A. Golbraikh, M. D. Shenderovich, J. Finne, and N. V. Bovin. 1993. Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides. Virology 196:111-121.
10. Mochalova, L., A. Gambaryan, J. Romanova, A. Tuzikov, A. Chinarev, D. Katinger, H. Katinger, A. Egorov, and N. Bovin. 2003. Receptorbinding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs. Virology 313:473-480.
11. Garten, R. J., C. T. Davis, C. A. Russell, et al. 2009. Antigenic and genetic characteristics of swine-origin 2009 (A)H1N1 influenza viruses circulating in humans. Science 325:197-201.
12. Tumpey, T. M., T. R. Maines, N. Van Hoeven, L. Glaser, A. Solorzano, C. Pappas, N. J. Cox, D. E. Swayne, P. Palese, J. M. Katz, and A. García-Sastre. 2007. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315:655-659.
13. Ilyushina, N. A., E. A. Govorkova, T. E. Gray, N. V. Bovin, and R. G. Webster. 2008. Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses. PLoS Pathog. 4:e10000043.
14. Thompson, C. I., W. S. Barclay, M. C. Zambon, and R. J. Pickles. 2006. Infection of human airway epithelium by human and avian strains of influenza A virus. J. Virol. 80:8060-8068.
15. Hoffmann, E., J. Stech, Y. Guan, R. G. Webster, and D. R. Perez. 2001. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 146:2275-2289.
16. Reed, L. J., and H. Muench. 1938. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
17. Reuman, P. D., S. Keely, and G. M. Schiff. 1989. Assessment of signs of influenza illness in the ferret model. J. Virol. Methods 24:27-34.
18. Palmer, D. F., W. R. Dowdle, M. T. Coleman, and G. C. Schild. 1975. Advanced laboratory techniques for influenza diagnosis. Immunology series no. 6. U.S. Department of Health, Education, and Welfare, Center for Disease Control, Atlanta, GA.
19. Salomon, R., J. Franks, E. A. Govorkova, N. A. Ilyushina, H. L. Yen, D. J. Hulse-Post, J. Humberd, M. Trichet, J. E. Rehg, R. J. Webby, R. G. Webster, and E. Hoffmann. 2006. The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J. Exp. Med. 203:689-697.
20. Russell, R. J., S. J. Gamblin, L. F. Haire, D. J. Stevens, B. Xiao, Y. Ha, and J. J. Skehel. 2004. H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology 325:287-296.